- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/48 - Iso-indolesHydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
Patent holdings for IPC class C07D 209/48
Total number of patents in this class: 757
10-year publication summary
|
77
|
66
|
69
|
61
|
52
|
50
|
41
|
34
|
37
|
14
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17594 |
19 |
| Amgen Inc. | 4071 |
12 |
| Cancer Research Technology Limited | 518 |
11 |
| FUJIFILM Corporation | 29295 |
10 |
| The Scripps Research Institute | 1347 |
8 |
| SHPP Global Technologies B.V. | 1084 |
8 |
| Siemens Medical Solutions USA, Inc. | 1510 |
7 |
| ExxonMobil Chemical Patents Inc. | 4012 |
7 |
| Arvinas Operations, Inc. | 225 |
7 |
| Boehringer Ingelheim International GmbH | 4697 |
6 |
| Syngenta Participations AG | 1907 |
6 |
| Wisconsin Alumni Research Foundation | 3872 |
6 |
| Astex Therapeutics Limited | 237 |
6 |
| Celgene Corporation | 1410 |
6 |
| SABIC Global Technologies B.V. | 4326 |
6 |
| The Trustees of Princeton University | 1199 |
6 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2842 |
6 |
| Vectus Biosystems Limited | 35 |
6 |
| Zeon Corporation | 4079 |
6 |
| Massachusetts Institute of Technology | 10030 |
5 |
| Other owners | 603 |